Media coverage
3
Media coverage
Title Aeglea BioTherapeutics to Present Updated Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency in an Oral Presentation at the 2019 Annual Meeting of the Society for Inherited Metabolic Disorders Media name/outlet Morningstar.com Country/Territory United States Date 1/04/19 URL https://www.morningstar.com/news/globe-news-wire/GNW_7567509/aeglea-biotherapeutics-to-present-updated-phase-12-data-for-pegzilarginase-in-patients-with-arginase-1-deficiency-in-an-oral-presentation-at-the-2019-annual-meeting-of-the-society-for-inherited-metabolic-disorders.html Persons George Diaz Title Aeglea BioTherapeutics to Present Updated Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency in an Oral Presentation at the 2019 Annual Meeting of the Society for Inherited Metabolic Disorders Media name/outlet GlobeNewswire Country/Territory United States Date 1/04/19 URL www.globenewswire.com/news-release/2019/04/01/1790602/0/en/Aeglea-BioTherapeutics-to-Present-Updated-Phase-1-2-Data-for-Pegzilarginase-in-Patients-with-Arginase-1-Deficiency-in-an-Oral-Presentation-at-the-2019-Annual-Meeting-of-the-Society.html Persons George Diaz Title AEGLEA BIO THERAPEUTICS : BioTherapeutics to Present Updated Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency in an Oral Presentation at the 2019 Annual Meeting of the Society for Inherited Metabolic Disorders Media name/outlet MarketScreener.com Country/Territory United States Date 1/04/19 URL https://www.marketscreener.com/AEGLEA-BIO-THERAPEUTICS-I-27114072/news/Aeglea-Bio-Therapeutics-BioTherapeutics-to-Present-Updated-Phase-1-2-Data-for-Pegzilarginase-in-Pa-28329452/ Persons George Diaz